Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
Abstract Introduction While multiple myeloma (MM) is a rare diagnosis within primary care, its precursor MGUS (monoclonal gammopathy of undetermined significance) is more common, particularly among older populations. Upon first detection, the majority of MGUS patients will be under the care of their...
Main Authors: | Charlene M. McShane, Blain Murphy, Olinda Santin, Lesley A. Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Family Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12875-019-0944-5 |
Similar Items
-
Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01) -
The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01) -
Progression patterns in monoclonal gammopathy of undetermined significance and multiple myeloma outcome: a cohort study in 42 patients
by: Widad Tahiru, et al.
Published: (2022-02-01) -
Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma
by: Sarah eTete, et al.
Published: (2014-06-01) -
Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)